L

Labiana Health SA
MAD:LAB

Watchlist Manager
Labiana Health SA
MAD:LAB
Watchlist
Price: 3.66 EUR -1.08% Market Closed
Market Cap: 26.4m EUR

Gross Margin
Labiana Health SA

62.5%
Current
61%
Average
48.6%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
62.5%
=
Gross Profit
41.4m
/
Revenue
66.3m

Gross Margin Across Competitors

Country Company Market Cap Gross
Margin
ES
Labiana Health SA
MAD:LAB
25.6m EUR
63%
US
Eli Lilly and Co
NYSE:LLY
739.9B USD
82%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
56%
US
Johnson & Johnson
NYSE:JNJ
375.3B USD
68%
DK
Novo Nordisk A/S
CSE:NOVO B
1.9T DKK
84%
CH
Roche Holding AG
SIX:ROG
204.9B CHF
74%
CH
Novartis AG
SIX:NOVN
190.5B CHF
76%
UK
AstraZeneca PLC
LSE:AZN
158.2B GBP
82%
US
Merck & Co Inc
NYSE:MRK
203.6B USD
78%
IE
Endo International PLC
LSE:0Y5F
163.5B USD
68%
US
Pfizer Inc
NYSE:PFE
144.3B USD
75%

Labiana Health SA
Glance View

Market Cap
25.3m EUR
Industry
Pharmaceuticals

Labiana Health SA manufactures sterile and lyophilized dosage forms. The company is headquartered in Pozuelo De Alarcon, Madrid and currently employs 477 full-time employees. The company went IPO on 2022-06-24. The Firm, through its subsidiaries, is engaged in the development, manufacturing and marketing of animal and human medicines. The Company’s main activities are: Drug research and development (R&D), which includes galenic and analytical development; Drug manufacturing, which focuses on formulation development, formulation optimization, bacterial vaccine manufacturing, among others; Regulatory services, which carries out registration procedures for pharmaceutical products in world markets. The Company, through its subsidiaries, is present in Ecuador, Mexico, Serbia and Turkey.

LAB Intrinsic Value
10.36 EUR
Undervaluation 65%
Intrinsic Value
Price
L
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
62.5%
=
Gross Profit
41.4m
/
Revenue
66.3m
What is the Gross Margin of Labiana Health SA?

Based on Labiana Health SA's most recent financial statements, the company has Gross Margin of 62.5%.

Back to Top